arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Monday 2 July 2018

Monday 02 Jul

09:00

PS3 Translational mycology / From laboratory discovery to patient care

Donald Sheppard, Canada

10:00

Break

10:30

Parallel session IV

Parallel session IV will take place from 10:30 hrs. until 12:00 hrs. and consists of six symposia.

S4.1 Molecular and cell biology of fungal pathogens

Convener: Neil Gow, United Kingdom

10:30

S4.1a The cell biology of cell walls of fungal pathogens and the interaction with immune cells

Neil Gow, United Kingdom

10:55

S4.1b Cell biology and structure of the Candida cell wall

Megan Lenardon, Australia

11:20

S4.1c Haploid Candida albicans as a powerful tool for new discoveries

Yue Wang, Singapore

11:45

S4.1d Dysfunction in complex I of Candida albicans influences the phagocytosis and killing ability of macrophage and colonization in mice intestine

Xiaodong She, China

S4.2 Cryptococcal meningitis clinical trials

Convener: Tihana Bicanic, United Kingdom

10:30

S4.2a ACTA and beyond

Thomas Harrison, United Kingdom

10:55

S4.2b New and novel agents for prevention of cryptococcal disease

David Boulware, USA

11:20

S4.2c AmBition-CM: High dose Liposomal Amphotericin for HIV related cryptococcal meningitis

William Hope, United Kingdom

11:45

S4.2d Dynamic ploidy changes drive emergence of fluconazole resistance in human cryptococcal meningitis

Neil Stone, United Kingdom

S4.3 Antifungals Pipeline session

Chair: Roger Brüggemann, the Netherlands

10:30

S4.3a CD101 – Cidara

Taylor Sandison, USA

10:55

S4.3b F901318 - F2G

John Rex, United Kingdom

11:20

S4.3c SCY-078 - Scynexis

David Angulo, USA

11:45

S4.3d VT-1598 - Viamet

Ed Garvey, USA

S4.4 Invasive infections in Asia

Conveners: Arunaloke Chakrabarti, India & Ruo-yu Li, China

10:30

S4.4a The unique features and challenges of yeast infections in Asia: focus on Candida tropicalis

Yee-Chun Chen, Taiwan

10:55

S4.4b Black mycelial fungal infection with special reference to Cladophialophora bantiana - Asian perspectives

Retno Wahyuningsih, Indonesia

11:20

S4.4c How to guard the mimic fungal infection in Asia?

Ariya Chindamporn, Thailand

11:45

S4.4d Fereydounia khargensis, an emerging Ustilaginomycetous opportunistic yeast, and antifungal resistances

Ratna Mohdtap, Malaysia

S4.5 New insights in the management of invasive fungal disease in haematology

Convener: Peter Donnelly, the Netherlands

10:30

S4.5a Invasive aspergillosis: New risk groups

Livio Pagano, Italy

10:55

S4.5b New management strategies (EORTC study)

Peter Donnelly, the Netherlands

11:20

S4.5c New antifungals (isavuconazole, new formulations of posaconazole, drugs in the pipeline)

Johan Maertens, Belgium

11:45

S4.5d New guidelines (ECCMID Aspergillus, IDSA Aspergillus and ECIL2017)

Fanny Lanternier, France

S4.6 MMCR case report session

Convener: Oliver Kurzai, Germany & Katrien Lagrou, Belgium

10:30

S4.6a Case 1

Shivaprakash Rudramurthy, India

10:55

S4.6b Case 2

Jochem Buil, the Netherlands

11:45

S.4.6c Case 3

Rachel Caligiorne, Brazil

12:00

Lunch break

Poster Pitch session III

12:15 - 13:15 (Ruby lounge, first floor)

13:30

PS4 Clinically validation and implementation of next generation sequencing into a clinical laboratory for patient care testing

Sean Zhang, USA

14:30

Break

15:00

Plenary session V

Parallel session V will take place from 15:00 hrs. until 16:30 hrs. and consists of six symposia.

S5.1 Hot topics in Taxonomy – Can we define fungal species borders?

Convener: June Kwon-Chung, USA

15:00

S5.1a Viewing species complexes through a phylogenomic lens – the Curious Case of Cryptococcus

David Engelthaler, USA

15:25

S5.1b What should be the ideal criteria for species delimitation in pathogenic fungi?

John Taylor, USA

15:50

S5.1c Mitochondrial genomes and species boundaries in the genus Fusarium

Balász Brankovics, the Netherlands

16:15

S5.1d Evolution of virulence genes and cryptic speciation in the fungal pathogen Histoplasma 

Victoria Sepúlveda, USA

S5.2 Superficial dermatophytes

Conveners: Ryoji Tsuboi, Japan & Ruoyu Li, China

15:00

S5.2a Epidemiology and clinical implication of dermatophytes and nondermatophytes in South East Asia

Sumanas Bunyaratavej & Charussri Leeyaphan, Thailand

15:25

S5.2b Cutaneous infection by zoonotic dermatophytes: an update

Pei-lun Sun, Taiwan

15:50

S5.2c Molecular epidemiology of dermatophytoses

Mochizuki Takashi, Japan

16:15

S5.2d New oral and topical treatments for onychomycosis

Ryoji Tsuboi, Japan

S5.3 Beyond antifungal / host directed therapy

Convener: Mihai Netea, the Netherlands

15:25

S5.3a Host-directed therapy in candidemia

Mihai Netea, the Netherlands

15:25

S5.3b New insights in diagnosis and immunopathology of aspergillosis

Agostinho Carvalho, Portugal

15:50

S5.3c New insights in Cryptococcus infections

Robin May, United Kingdom

16:15

S5.3d Quantifying host-pathogen interaction in blood from patients with selected immunodeficiencies

Kerstin Hünniger, Germany

S5.4 Mucoralean infections

Convener: Anna Skiada, Greece

15:00

S5.4a Managing mucormycosis: why is it so difficult? 

Ashraf Ibrahim, USA

15:25

S5.4b Diagnostics: From histopathology and cultures to qPCR

Birgit Willinger, Austria

15:50

S5.4c Challenging Cases of Mucormycosis

Rajeev Soman, India

16:15

S5.4d Mucormycosis in patients with hematological diseases after hematopoietic stem cell transplantation and chemotherapy

Yuliya Rogacheva, Russia

S5.5 From Basic Science to Patient Care

Convener: Dieter Buchheidt (DMykG) & Jacques Meis, the Netherlands

15:00

S5.5a Translating antifungal immunology into patient care

Frank van de Veerdonk, the Netherlands

15:30

S5.5b Translating mycology into patient care

Oliver Kurzai, Germany

16:00

S5.5c Clinical challenges in the management of invasive fungal infections

Andreas Groll, Germany

16:15

S5.5d Candida auris: understanding the mechanisms of host immune response

Mariolina Bruno, the Netherlands

S5.6 ISHAM Working Group: Fusarium

Conveners: Anne van Diepeningen, the Netherlands & Abdullah Al-Hatmi, Oman

15:00

S5.6a The trans-kingdom pathogen Fusarium

Anne van Diepeningen, the Netherlands

15:25

S5.6b Fusarium keratitis: the species and their occurrence

Grit Walther, Germany

15:50

S5.6c Intrinsic resistance to antifungals

Joseph Meletiadis, Greece

16:15

5.6d Histological characterization and host response during Fusarium solani infection in an ex-vivo human skin model

Dora Corzo-Leon, United Kingdom

16:30

Parallel session VI

Parallel session VI will take place from 16:30 hrs. until 18:00 hrs. and consists of six symposia.

S6.1 Functional genomics and systems biology

Convener: Berhard Hube, Germany

16:30

S6.1a QPCR detection of Mucorales DNA in bronchoalveolar lavage fluid for pulmonary mucormycosis diagnosis

Laurence Millon, France

16:55

S6.1b Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia

Judith Berman, Israel

17:20

S6.1c Functional genomics of Candida species

Geraldine Butler, Ireland

17:45

S6.1d Comparative genomics for understanding the development of multidrug resistance in Candida lusitaniae

Dominique Sanglard, Switzerland

S6.2 ABPA

Convener: Ritesh Agarwal, India

16:30

S6.2a Recent advances in allergic bronchopulmonary aspergillosis complicating asthma

Arunaloke Chakrabarti, India

16:30

S6.2b Severe asthma with fungal sensitization

David Denning, United Kingdom

17:20

S6.2c Recent advances in allergic bronchopulmonary aspergillosis complicating cystic fibrosis

Richard Moss, USA

17:45

S6.2d A new Aspergillus fumigatus Western Blot assay for IgE sensitization and Allergic Broncho Pulmonary Aspergillosis diagnosis

Raphael Piarroux, France

S6.3 Tropical implantation diseases

Convener: Flavio Queiroz-Telles, Brazil

16:30

S6.3a Management of chromoblastomycosis : difficulties, challenges and perspectives in developing countries

Lala Soavina Ramarozatovo, Madagascar

16:55

S6.3b The expanding cat-transmmited sporotrichosis in Brazil

Anderson Rodrigues, Brazil

17:20

S6.3c Diversity among coelomycetous isolates from cutaneous and subcutaneous infections

Dea Garcia-Hermoso, France

17:45

S6.3d Conidiobolomycosis: presentation of two cases in adult and infant

Alexandro Bonifaz, Mexico

S6.4 Aspergillus terreus frontline

Convener: Cornelia Lass-Flörl, Austria

16:30

S6.4a The Aspergillus terreus species complex: What is new

Jesus Guinea, Spain

16:55

S6.4b Outcome and treatment of Aspergillus terreus infections

Oliver Cornely, Germany

17:20

S6.4c Amphotericin B Resistance: New insights

Cornelia Lass-Flörl, Austria

17:45

S6.4d Molecular epidemiology and antifungal susceptibility profiles of Aspergillus terreus in Iran

Afsane Vaezi, Iran

S6.5 Malassezia in humans and animals

Conveners: Jacques Guillot, France & Teun Boekhout, the Netherlands

16:30

S6.5a Analysis of Malassezia microbiota in humans and animals: does it really help us to better understand and control Malassezia-related diseases?

Jacques Guillot, France

16:55

S6.5b The human skin microbiome: cause or effect? The role of Malassezia in human skin health and disease.

Thomas Dawson, Singapore

17:20

S6.5c The overgrowth of Malassezia spp.in canine atopic dermatitis - the reason or the result of disease?

Bozena Dworecka-Kaszak, Poland

17:45

S6.5d Characterization of growth of lipid-dependent Malassezia yeast species, members of the skin mycobiome

Hans de Cock, the Netherlands

S6.6 Surveillance azole resistance

Convener: Jacques Meis, the Netherlands

16:30

S6.6a Surveillance of azole resistance in Colombia

Patrice le Pape, France

16:55

S6.6b Surveillance and status quo of azole resistant Aspergillus in East Asia

Chi-Jung Wu,Taiwan

17:20

S6.6c First report of azole-resistant Aspergillus fumigatus harboring TR34/L98H and M220R in Brazil

Laura Bedin Denardi, Brazil

17:45

S6.6d Status and Surveillance of Azole Resistance in North America

Elizabeth Berkow, USA

18:00

Poster Pitch Session IV

18:00 - 19:00 Ruby Lounge (first floor)

19:00

Young ISHAM Evening

19:00

ISHAM/ECMM/GAFFI Outreach Evening Eastern Europe

This evening program is only accessible for invited delegates

Monday 02 Jul

Poster Pitch session III

Poster Terminal 1

12:15

PP3.017 - ZnO nanoparticles coated by Chitosan-Linoleic acid inhibit the Candida growth and Biofilm formation in vitro

M. Roudbary, Iran

12:22

PP3.018 - AtrR, an essential regulator of azole resistance in Aspergillus fumigatus, acts via the TR34 element in the cyp51A promoter

Scott Moye-Rowley, USA

12:29

PP3.019 - Aspergillus fumigatus strains are adapted to the lung environment in a case of chronic pulmonary aspergillosis

Sara Gago, United Kingdom

12:36

PP3.020 - Antifungal Activity and Cytotoxic Effect of Echinophora Extract, Carvacrol and Drug Caspofungin on Vaginal Candida albicans Infections on Cervical Cancer

Mohammad Yadegari, Iran

12:43

PP3.021 - Environmentally acquired mutations in Aspergillus fumigatus leading to azole resistance: An Asian situation

Yubhisha Dabas, India

12:50

PP3.022 - Concomitant isolation of Aspergillus species and Mycobacterium species in respiratory tract of patients: an underestimated microbial interaction?

Sarah Dellière, France

12:57

PP3.023 - Posaconazole tablet therapeutic drug monitoring in patients with chronic pulmonary aspergillosis

Chris Kosmidis, United Kingdom

13:04

PP3.024 - Aspergillus fumigatus fumagillin as possible virulence factor

Xabier Guruceaga, Spain

Poster Terminal 2

12:15

PP3.057 - Multiplex qPCR for rapid identification of Candida auris, C. haemulonii, C. duobushaemulonii and C. pseudohaemulonii

Amir Arastehfar, the Netherlands

12:22

PP3.058 - Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model

Hamed Fakhim, Iran

12:29

PP3.059 - CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates

Cosmeri Rizzato, Italy

12:36

PP3.060 - Severe recurrent vulvovaginal Candidiasis caused by mixed Candida species

Mohammad Effat, Egypt

12:43

PP3.061 - Optimization and application of fluorescent proteins in super-resolution microscopy of Candida albicans

Wouter Van Genechten, Belgium

12:50

PP3.062 - Ca37 monoclonal antibody inhibits Candida albicans growth in vitro and in vivo

Aitziber Antoran, Spain

12:57

PP3.063 - Activity of investigational tetrazole antifungals VT-1161 and VT-1598 against a collection of clinical Candida tropicalis isolates with reduced fluconazole susceptibility

Jeffrey Rybak, USA

Poster Terminal 4

12:15

PP3.097 - Development of echinocandin resistance after in vitro micafungin exposure in clinical isolates of Candida glabrata

Olga Rivero-Menendez, Spain

12:22

PP3.098 - Mechanisms of invisibility: 3D, real time and holographic imaging reveals dynamics of Candida albicans evasion of host recognition

Jude Bain,UK

12:29

PP3.099 - Photodynamic inactivation can fight biofilms of Candida albicans strains with constitutive efflux

Helena Bujdáková, Slovak Republic

12:36

PP3.100 - In vitro study of photodynamic inactivation against Fonsecaea monophora and the application of ALA-APDT on refractory Chromoblastomycosis

Liyan Xi, China

12:43

PP3.101 - Restoration Melanin of Fonseace monophora reduced Its Pathogenicity to Galleria mellonella

Yinghui Liu, China

12:50

PP3.102 - High-throughput RNA sequencing (RNA-seq) analysis of macrophages infected with Fonsecaea monophora

Junmin Zhang China

12:57

PP3.103 - Fungal eye infections among ophthalmologic patients at ABSUTH, Aba, Abia State, Nigeria

Ada Ngwogu, Nigeria

Poster Terminal 5

12:15

PP3.137 - In vitro inducing conditions to promote titan-like cells formation in C. neoformans

Rocio García-Rodas, Spain

12:22

PP3.138 - Novel Dermatophytes from Indian soils

Rahul Sharma, India

12:29

PP3.139 - In vitro and in vivo efficacy and toxicity of nonyl 3,4-dihydroxybenzoate, a potent compound against dermatophytes biofilms

Caroline Costa-Orlandi, Brazil

12:36

PP3.140 - New and emerging zoophilic dermatophytes in Europe

Adela Cmoková, Czech Republic

12:43

PP3.141 - Emergence of Trichophyton benhamiae in guinea pigs: a retrospective study from the mycology laboratory of the veterinary college of Alfort

Jacques Guillot, France

12:50

PP3.142 - Molecular epidemiology of Trichophyton mentagrophytes – a new approach

Silke Uhrlass, Germany

12:57

PP3.143 - A national survey on Tinea capitis in France: epidemiology and diagnostic procedures

Jean-Pierre Gangneux, France

13:04

PP3.144 - Place of Trichophyton soudanense in the Trichophyton rubrum complex: a clinical isolates analysis

Maud Gits-Muselli, France

Poster Terminal 6

12:15

PP3.177 - Conductivity: A novel approach for antifungal susceptibility testing

Srivastava Neelabh, India

12:22

PP3.178 - Interactions with fungal cell wall polysaccharides determines the salt tolerance of antifungal plant defensins

Mark Bleackley, Australia

12:29

PP3.179 - The plant defensin HXP124 has the potential to be a new safe and effective topical treatment for onychomycosis

Nicole Van der Weerden, Australia

12:36

PP3.180 - The antifungal mechanism of action for plant defensins is defined via treatment of a barcoded yeast deletion libraryf

Kathy Parisi, Australia

12:43

PP3.181 - Fungal study of guano bat samples

Cristine Goebel, Brazil

12:50

PP3.183 - Impaired phagocytosis directs human monocyte activation in response to fungal derived ß-glucan particles

Jessica Quintin, Brazil

12:57

PP3.184 - Cutaneous infection caused by Fusarium lichenicola in a patient with verrucous hyperplasia vermiculatum manifestation

Sha Lu, China

Poster Terminal 8

12:15

PP3.217 - Genome mining and transcriptomic analysis of iron metabolism genes in Scedosporium apiospermum

Yohann Le Govic, France

12:22

PP3.218 - Production of Scedosporium boydii CatA1 and SodC recombinant proteins: another step towards a standardized test for serodiagnosis of Scedosporium infections

Sara Mina, Lebanon

12:29

PP3.219 - Hybrid histidine kinase III: new therapeutic target for Scedosporium apiospermum?

Anaïs Hérivaux, France

12:36

PP3.220 - Lignin degradation pathway in Scedosporium species

Wilfried Poirier, France

Monday 02 Jul

Poster Pitch session IV

Poster Terminal 1

18:00

PP4.025 - Molecular identification and antifungal susceptibility testing of fungal agents isolated from patients with idiopathic pulmonary fibrosis(IPF) in Tehran, Iran

M. Roudbary, Iran

18:07

PP4.026 - Isolation of Aspergillus species in respiratory specimens from adult patients with acute exacerbation of non-cystic fibrosis bronchiectasis; Data from Pakistan

Kauser Jabeen, Pakistan

18:14

PP4.02 - Azole resistance in Aspergillus fumigatus. Frequency and distributions of mutations in a tertiary center in the Netherlands

Jochem Buil, the Netherlands

18:21

PP4.028 - Development and multicentre evaluation of a screening method for echinocandin susceptibility testing of Aspergillus spp.

Joseph Meletiadis, Greece

18:28

PP4.029 - Molecular identification and antifungal susceptibility patterns of invasive Aspergillus species following CLSI and EUCAST guidelines

Yubhisha Dabas, India

18:35

PP4.030 - The IL17RA and CARD10 genes are important in controlling Aspergillus fumigatus colonisation of the lung in allergic bronchopulmonary aspergillosis

Sara Gago, United Kingdom

18:42

PP4.032 - Overexpression of cyp51A and cyp51b contribute to triazole resistance in clinical isolates of Aspergillus fumigatus from the United States

Jeffrey Rybak, USA

Poster Terminal 2

18:00

PP4.065 - Modulation of Candida albicans infection by the non-selective muscarinic receptor agonist pilocarpine hydrochloride

Christopher Nile, United Kingdom

18:07

PP4.066 - Do Candida albicans biofilms contain persister cells?

Iryna Denega, France

18:14

PP4.067 - Identification of recessive lethal alleles in the Candida albicans genome: a constraint on loss-of-heterozygosity events in this species

Melanie Legrand, France

18:21

PP4.068 - Healthcare linen as a source of a mucormycosis case cluster that involved different sites of infection and different Mucorales species

Hong Nguyen, USA

18:28

PP4.069 - Genetically closely related azole-resistant Candida tropicalis in environments can be a threat to healthcare

Zi-Li Zhou, Taiwan

18:35

PP4.070 - Mapping the interaction of the Candida albicans multidrug resistance ABC protein Cdr1 with pump inhibitor clorgyline that stimulates ATPase activity

Masakazu Niimi, Thailand

18:42

PP4.071 - Metabolic adaptation triggers Candida albicans biofilm phenotype

Gordon Ramage, United Kingdom

18:49

PP4.072 - The use of long and short-read sequencing technology to elucidate genomic variation and epidemiology of Candida glabrata in North America

R.M. Welsh, USA

Poster Terminal 4

18:00

PP4.105 - YEAST PANEL Multiplex PCR Assay for Identification of Invasive Yeast Pathogens: Novel Diagnostic Strategy, Useful for Developing Countries

Amir Arastehfar, the Netherlands

18:07

PP4.106 - Increasing trend of mucormycosis mixed with other invasive mycoses from a tertiary care centre in north India

Jagdish Chander, India

18:14

PP4.107 - Invasive fungal diseases in patients with acute leukemia or allogeneic stem cell transplantion recepients: A prospective multicenter observational study

Gokhan Metan, Turkey

18:21

PP4.108 - A genetic and genomics approach identifies novel pathways of human antifungal immune responses

Vinod Kumar Magadi Gopalaiah, the Netherlands

18:28

PP4.109 - Epidemiology of fungaemia and fungal meningitis in Sweden: a nationwide retrospective observational survey from sept 2015-aug 2016

Lena Klingspor, Sweden

18:35

PP4.110 - Comparative sequencing of ITS and D1/D2 domains of ribosomal DNA for Molecular discrimination of fungal moulds

Baskar Raju, India

18:42

PP4.111 - Molecular diagnostics of arthroconidial yeasts– frequent pulmonary opportunists

Engin Kaplan, Turkey

18:49

PP4.112 - Neglected diseases in Nigerians, diagnostics challenges: Invasive Fungal Infections

Rita Oladele, Nigeria

Poster Terminal 5

18:00

PP4.145 - Prevalence and virulence of the zoophilic dermatophyte Trichophyton benhamiae

Yvonne Gräser, Germany

18:07

PP4.146 - Epidemiology of dermatophytosis in the Caribbean

Harish Gugnani, India

18:14

PP4.148 - Long-term practice of animal vaccination against dermatophytosis

Marina Manoyan, Russia

18:21

PP4.151 - Application of real-time PCR assays for the diagnosis of histoplasmosis using three molecular targets in human FFPE tissues and whole-blood

Beatriz Lucia Gomez, Colombia

18:28

PP4.152 - Metagenomic analysis of environmental samples from mycetoma endemic area in Sudan

S.M. Bakhiet, Sudan

Poster Terminal 6

18:00

PP4.185 - Topical use of 1% luliconazole cream cured with Fusarium oxysporum infected refractory ulcers on an elderly patient’s leg and ankle

Xin Ran, China

18:07

PP4.186 - Primary cutaneous Fusarium solani infection in a hemodialysis patient

Dongmei Shi, China

18:14

PP4.187 - Biological activity of lipids extracted from two isolates of Fusarium oxysporum (environmental and clinical) in Galleria mellonella

Pedronel Araque, Colombia

18:21

PP4.188 - Diversity of clinically relevant Fusarium species complexes: preliminary analysis of from an 11-yr prospective surveillance in France

Dea Garcia-Hermoso, France

18:28

PP4.189 - Epidemiology and in vitro susceptibility of Fusarium species from human infections in Germany – results of a retrospective multicenter study

Axel Hamprecht, Germany

18:35

PP4.190 - Type 17 immunity controls Malassezia skin infection

Florian Sparber, Switzerland

18:42

PP4.191 - A rapid molecular assay for direct quantification of Malassezia pachydermatis in otic swabs

Gemma Castellá, Spain

18:49

PP4.192 - 'PepBiotics', novel antimicrobial peptides to fight fungal infections caused by Aspergillus fumigatus and Malassezia furfur

Hans De Cock, the Netherlands